Market Research Trends

Spinal Stenosis is narrowing of the spinal column and mainly occurs from a combination of aging and degenerative changes in the spine. This puts pressure on the spinal cord and the spinal nerve roots, and may cause pain, numbness, or weakness in the legs. Spinal stenosis mostly affects people above 60 years of age but can also occur in younger people born with the abnormal spinal canal. Lumbar spinal stenosis, cervical spinal stenosis and thoracic spinal stenosis are the three main types of spinal stenosis. About 75% of the cases of spinal stenosis occurs in the lower lumbar region. The primary symptoms associated with spinal stenosis are radiculopathy and myelopathy. Myelopathy is of greater concern as pressure on the spinal cord can lead to permanent spinal cord damage.  Diagnosis of spinal stenosis involves the complete evaluation of spine. The most common diagnostic test for spinal stenosis are MRI scan and X-ray. In some cases CT scan can be conducted in order to diagnose t

Opioids are a class of medications that are regularly endorsed for their pain relieving, or pain-killing, properties it is chronic and non-cancer pain. A typical symptom connected with the utilization of these medications are that they decrease the gastrointestinal tract's motility, making solid discharges and making patients strain. In addition, prolonged utilization of opioids can prompt the harm of sensory system that causes body cells to quit creating endogenous opioids, for example, endorphins. There is high risk of constipation in adults since they have poor diet, poor fluid intake and immobility. The typical symptoms for opioid-induced constipation are feeling lethargic, hard and dry stools, distention and bulged abdomen, painful defecation and loss of appetite. The opioid-induced constipation (OIC) treatment market is an exceptionally alluring and promising market because of the expanding base of opioid-induced constipation OIC sufferers. Opioid-Induced Constipation

Adult and Pediatric Hemoconcentrators Market Overview The  Adult and Pediatric Hemoconcentrators Market  is anticipated to record a CAGR of 3% during the forecast period, to reach a valuation of US$ 14.1 Mn by 2027. Sales of adult and pediatric hemoconcentrators  are expected to rise as perfusionists and surgeons are increasingly relying on hemoconcentrators to maintain higher hematocrit levels during cardiopulmonary surgery. In addition to this,  demand for adult and pediatric hemoconcentrators  is rising on account of heart diseases becoming more common over the world. The increasing frequency of cardiovascular disorders in low-income nations has prompted an emphasis on cardiac care, which is projected to contribute to the growth of the  adult and pediatric hemoconcentrators market share. The report sheds light on the factors improving the  sales of adult and pediatric hemoconcentrators  and, in turn, the opportunities for the market players. However, the  adult and pediatric

Tissue Diagnostics Market Overview The global  Tissue Diagnostics Market  was valued at US$ 32.0 Bn in 2021 and is set to expand at a healthy CAGR of 12.8% during 2022-2032, with a market valuation of US$ 120.2 Bn by 2032. “Upsurge in the cancer incidences and rising presence of various medical and biotechnology firms across the world is expected to uplift the tissue diagnostics market growth.” A group of human cells that play an important role in executing several biological functions that are crucial for other healthy functions in the human body are referred to as tissues. Tissue diagnostics is an important field of diagnostics research. The tissue sample explains several aspects of the different biological situations. Tissue diagnostics have played a major role in the field of cancer analysis and diagnostics. It helps researchers and scientists to identify the presence of cancer by examining the tissue samples. It is also gaining popularity in the different diagnostic fields

Intra-gastric Balloons Market Overview Studies reveal that over 2 billion people are suffering from obesity and about 3 million people lose their lives each year due to obesity. Intra-gastric balloons have emerged as a boon for shedding weight and reducing obesity. The healthcare sector is increasingly shifting towards non to minimally invasive procedures from surgical weight loss treatments, keeping patient convenience at top. Faster approvals from regulatory bodies such as the US FDA and its associated treatment followed by the American Society for Metabolic and Bariatric Surgery are further standardizing the application of intra-gastric balloons. Intra-gastric Balloons Market – Growth Trends High adoption of minimally invasive surgeries by obese patients, owing to increased risks from invasive weight-loss treatments, is fueling the demand for intra-gastric balloons. Intra-gastric balloons are gaining a good reputation as they are cost-effective. According to the America

Medical Dispenser Market Overview The practice of healthcare is dynamic in nature, and the demand for increased efficiency in drug dispensation count and the need for elimination of life-threatening human errors worldwide are anticipated to act as the primary influencing factors behind the growth of the Medical Dispenser market through the forecast period. Concerns Over Medication Errors by Healthcare Professionals to Drive the Growth of the Medical Dispenser Market According to the Institute of Medicine over 5000 deaths take place every year worldwide due to human errors in the medicine dispensation process, which arise from negligence or lack of skilled resources for the task. The growing number of patients and their individual needs of treatment make the dispensation of medicines a complex and detail oriented process. As a result of this, dispensing errors are considered as one of the leading causes of medicine related deaths globally. Growing concerns over the correct di

Influenza Vaccine Market Overview Influenza Vaccine typically known as flu shot and is used for protection against influenza virus. An influenza vaccine is a combination of three viruses types namely, influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain and influenza type B virus strain. Influenza is a contagious respiratory illness caused by influenza viruses, which may cause mild to severe illness. Severity of the illness might land up to hospitalization or death. The risk of the serious flu complication is more in the age group such as older people, young children, and people with certain health conditions. It should be a habit to get vaccinated every year against this virus, as part of the best practice to avoid getting infected. The categorization of this influenza virus is done into the mentioned categories, influenza A (H1N1) virus, an influenza A (H3N2) virus, and one or two influenza B viruses, depending on the flu vaccine. Patients show symp

Personalized Medicine are drugs that are based on individual patient or intended patient groups carrying certain biomarkers and are created to cater the requirement of an individual patient based on the response produced by the patient suffering from a particular disease. The personalized medicines are currently in focus due to their effectiveness in cancer patients and patients suffering from rare genetic disorders. The fact that this approach could do away with the “One Size Fits All” approach leads to anticipations regarding higher treatment effectiveness through customization of prevention, prediction and treatments. In this regard, funds worth EUR 1 Bn has been invested by the EU as of 2015, focused on the development of personalized medicine, through its Seventh Framework Program for Research and Technological Innovation. The EU is also known to be coordinating with the member states on Health Technology Assessment for better understanding on cost-benefit-efficiency of including